Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
    April 2024
  1. ZENGIN HB, Tan PH, Liu R, Smoller BR, et al
    'Eczematous' dermatitis of the nipple: clinical and histopathological differential diagnosis of Paget disease.
    Pathology. 2024;56:300-312.
    >> Share

  2. TAY TKY, Tan GS, Lee SH, Sam XX, et al
    Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers.
    Pathology. 2024;56:325-333.
    >> Share

    March 2024
  3. WU Y, Chen F, Pan L, Chao X, et al
    Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Pathology. 2024 Mar 14:S0031-3025(24)00084-9. doi: 10.1016/j.pathol.2024.
    >> Share

    Predictive and prognostic biomarkers in breast tumours.
    Pathology. 2024;56:186-191.
    >> Share

    January 2024
  5. BAEZ-NAVARRO X, van Bockstal MR, Jager A, van Deurzen CHM, et al
    HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study.
    Pathology. 2024 Jan 18:S0031-3025(24)00007-2. doi: 10.1016/j.pathol.2023.
    >> Share

    October 2023
  6. ZENG L, Koh VCY, Tay TKY, Lee AC, et al
    Adenoid cystic carcinoma arising in association with an intraductal papilloma of the breast.
    Pathology. 2023;55:895-897.
    >> Share

    August 2023
  7. CHEN YY, Yang CF, Hsu CY
    The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer.
    Pathology. 2023 Aug 12:S0031-3025(23)00186-1. doi: 10.1016/j.pathol.2023.
    >> Share

  8. NGUYEN MA, Colebatch AJ, Van Beek D, Tierney G, et al
    NTRK fusions in solid tumours: what every pathologist needs to know.
    Pathology. 2023;55:596-609.
    >> Share

    June 2023
  9. TAN PH
    Refining the classification of breast phyllodes tumours.
    Pathology. 2023;55:437-448.
    >> Share

    April 2023
  10. NAMJOSHI A, Wong DD, Gill J
    A rare case of metastatic endometrial stromal sarcoma mimicking primary breast carcinoma: a diagnostic pitfall.
    Pathology. 2023;55:414-416.
    >> Share

    October 2022
  11. TSANG JY, Shao Y, Poon IK, Ni YB, et al
    Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
    Pathology. 2022;54:678-685.
    >> Share

  12. HARB M, Prince DS, Bassan M, Mackenzie S, et al
    Extra-mammary Paget's disease rising from a non-invasive rectal adenoma.
    Pathology. 2022;54:826-828.
    >> Share

    April 2022
  13. ROY SF, Wong J, Latour M, Reichetzer B, et al
    Ductal-type mesonephric duct/remnant hyperplasia: distinguished from lobular or diffuse mesonephric hyperplasia by the presence of a myoepithelial cell layer and micropapillary tufting.
    Pathology. 2022;54:378-381.
    >> Share

    February 2022
  14. LEE W, Law T, Lu Y, Lee TK, et al
    Mitotic counts in one high power field in breast core biopsies is equivalent to counts in 10 high power fields.
    Pathology. 2022;54:43-48.
    >> Share

  15. KATAYAMA A, Toss MS, Parkin M, Ellis IO, et al
    Atypia in breast pathology: what pathologists need to know.
    Pathology. 2022;54:20-31.
    >> Share

  16. HORT A, O'Toole SA, Yunaev M
    An unusual case of invasive lobular carcinoma with abundant extracellular mucin.
    Pathology. 2022;54:138-140.
    >> Share

    January 2022
  17. KUNC M, Peksa R, Cserni G, Izycka-Swieszewska E, et al
    High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.
    Pathology. 2022 Jan 21. pii: S0031-3025(21)00542.
    >> Share

    February 2021
  18. PAVER EC, Cooper WA, Colebatch AJ, Ferguson PM, et al
    Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
    Pathology. 2021;53:141-156.
    >> Share

  19. RAZVI H, Tsang JY, Poon IK, Chan SK, et al
    INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Pathology. 2021;53:170-178.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016